This inventor holds 1 USPTO granted patent. Top assignee: Blueprint Medicines Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Stefanie Sandra Schalm: Innovator in Protein Kinase A Inhibition
Introduction
Stefanie Sandra Schalm is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for protein kinase A. Her work is crucial for advancing therapeutic options in various medical conditions.
Latest Patents
Stefanie holds 1 patent related to her innovative research. The patent, titled "Inhibitors of Protein Kinase A," describes compounds capable of inhibiting protein kinase A and its mutants. It includes pharmaceutical compositions comprising these compounds, their pharmaceutically acceptable salts, and methods for their use.
Career Highlights
Stefanie is currently associated with Blueprint Medicines Corporation, where she continues to push the boundaries of scientific research. Her expertise in protein kinase inhibition has positioned her as a key player in the pharmaceutical industry.
Collaborations
[Section skipped due to space constraints.]
Conclusion
Stefanie Sandra Schalm's contributions to the field of protein kinase A inhibition exemplify her dedication to innovation in biochemistry. Her work not only enhances our understanding of this critical enzyme but also paves the way for new therapeutic strategies.